Trials / Completed
CompletedNCT00539773
Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Phase II Trial of concurrent administration of intravesical BCG \& Interferon in the treatment and prevention of recurrence of superficial transitional carcinoma of the urinary bladder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BCG, Interferon | Chemotherapy |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2007-10-05
- Last updated
- 2015-12-17
Source: ClinicalTrials.gov record NCT00539773. Inclusion in this directory is not an endorsement.